Overview / Abstract: |
To facilitate the diagnosis and management of alpha-1 antitrypsin deficiency (AATD), clinicians require an understanding of the patient and clinical characteristics that should prompt screening, including a family history and signs of lung or liver involvement. This educational tool supports an easy translation of knowledge and encourages informed decision making for screening and testing patients for AATD. Access expert commentary, resources, and an animated video to be shared with patients who have a high probability of AATD, to increase awareness around common conditions related to AATD, how it is screened, and how to communicate with their healthcare team. AATD is underrecognized even though early identification is so critical. Education is needed to support early diagnosis and management of patients with AATD. Early detection can slow AATD-related symptoms and disease progression, encourage healthy habits and lifestyle adjustments, and lead to beneficial interventions to improve disease prognosis and patients’ quality of life. |
Expiration |
Feb 24, 2024 |
Discipline(s) |
Nurse Practitioner , Nursing CNE, Physician CME, Physician Assistant CME |
Format |
Online, Webinar / Webcast / Video |
Credits / Hours |
0.75 AMA PRA Category 1 Credit(s)™ |
Accreditation |
ACCME |
Presenters / Authors / Faculty |
Caroline Jouhourian, MD Cheryl Pirozzi MD, MS |
Sponsors / Supporters / Grant Providers |
Supported by an educational grant from Takeda Pharmaceuticals U.S.A., Inc. |
Keywords / Search Terms |
ACHL CME, CE, Continuing Medical Education, CME/CE, Online Learning, Takeda, alpha-1 antitrypsin deficiency, AATD, AAT, A1AT, A1ATD, rare disease, liver disease, COPD, emphysema, Caroline Jouhourian, Cheryl Pirozzi, alpha-1, deficiency, asthma, bronchiectasis, genotype, neonatal, hepatitis, cholestasis, testing, screening, risk factor, serum level, phenotype, variant, pathogenic, lung, pulmonology, respiratory, family history Free CE CME |